Evaluation of western blot CagA seropositivity in Helicobacter pylori-seropositive and -seronegative subjects

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 2, 2005, Pages 304-309

  Simán, J Henrik ^a   Engstrand, Lars ^b   Berglund, Göran ^a   Claes Henri, Florén ^a   Forsgren, Arne ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CAGA PROTEIN, HELICOBACTER PYLORI;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ATROPHY; BACTERIAL INFECTION; DUODENUM ULCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; STOMACH ADENOCARCINOMA; STOMACH DISEASE; WESTERN BLOTTING; BLOOD; EPIDEMIOLOGY; HELICOBACTER INFECTION; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

EID: 22044448046     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.2.304-309.2005     Document Type: Article

References (13)

1. Blaser, M. J., G. I. Perez-Perez, H. Kleanthous, T. L. Cover, R. M. Peek, P. H. Chyou, G. N. Stemmermann, and A. Nomura. 1995. Infection with Helicobacterpylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111-2115.
2. Brenner, H., V. Arndt, G. Bode, C. Stegmaier, H. Ziegler, and T. Stumer. 2002. Risk of gastric cancer among smokers infected with Helicobacter pylori, Int. J. Cancer 98:446-449.
3. Ekström, A. M., M. Held, L. E. Hansson, L. Engstrand, and O. Nyrén. 2001. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 121:784-791.
4. Figueiredo, C., W. Quint, N. Nouhan, H. van den Munckhof, P. Herbrink, J. Scherpenisse, W. de Boer, P. Schneeberger, G. Perez-Perez, M. J. Blaser, and L.-J. van Doom. 2001. Assessment of Helicobacter pylori vacA and cagA genotypes and host serological response. J. Clin. Microbiol. 39:1339-1344.
5. Fusconi, M., D. Vaira, M. Menegatti, S. Farinelli, N. Figura, J. Holton, C. Ricci, R. Corinaldesi, and M. Miglioli. 1999, Anti-CagA reactivity in Helicobacter pylori-negative subjects: a comparison of three different methods. Dig. Dis. Sci. 44:1691-1695.
6. Gnarpe, H., P. Unge, C. Blomqvist, and S. Makitalo. 1988. Campylobacter pylori in Swedish patients referred for gastroscopy. APMIS 96:128-132.
7. Hamlet, A., A. C. Thoreson, O. Nilsson, A. M. Svennerholm, and L. Olbe. 1999. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology 116:259-268.
8. Helicobacter and Cancer Collaborative Group. 2001. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49:347-353.
9. Nomura, A. M., G. I. Pérez-Pérez, J. Lee, G. Stemmermann, and M. J. Blaser. 2002. Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am. J. Epidemiol. 155:1054-1059.
10. Parsonnet, J., G. D. Friedman, N. Orentreich, and H. Vogelman. 1997. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40:297-301.
11. Siman, J. H., A. Forsgren, G. Berglund, and C. H. Floren. 1997. Association between Helicobacter pylori and gastric carcinoma in the city of Malmö, Sweden. A prospective study. Scand. J. Gastroenterol. 32:1215-1221.
12. Sorberg, M., L. Engstrand, M. Strom, K. A. Jonsson, H. Jorbeck, and M. Granstrom. 1997. The diagnostic value of enzyme immunoassay and immunoblot in monitoring eradication of Helicobacter pylori. Scand. J. Infect. Dis. 29:147-151.
13. Stack, W. A., J. C. Atherton, G. M. Hawkey, R. F. Logan, and C. J. Hawkey. 2002. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment. Pharmacol. Ther. 16:497-506.